Amneal Pharmaceuticals Deal History & Licensing Activity
Amneal Pharmaceuticals is a large pharma headquartered in US. The company currently has 6 active clinical trials, primarily in CNS Disorders.
Deals (12mo)
3
Active Trials
6
Top Modality
N/A
Focus Area
CNS Disorders
Amneal Pharmaceuticals Pipeline Focus
Therapeutic areas and modalities where Amneal Pharmaceuticals is most active based on deal history and clinical trial data.
Therapeutic Areas
Amneal Pharmaceuticals Strategic Signals
Key indicators of Amneal Pharmaceuticals's licensing and acquisition strategy, including patent expirations, pipeline gaps, and strategic priorities.
Strategic Profile
Acquisition Appetite
Strategic Priorities
Amneal Pharmaceuticals Clinical Pipeline
Amneal Pharmaceuticals has 6 active clinical trials across 4 development phases.
2
Phase 4
2
Unknown
1
Phase 1
1
Phase 3
See How Your Asset Matches Amneal Pharmaceuticals's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for CNS Disorders assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Cardiovascular Deal Benchmarks
Market sizing, deal terms, and competitive landscape for cardiovascular
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Amneal Pharmaceuticals Licensing & Deal Activity
Amneal Pharmaceuticals is a large pharma company based in US that has been actively engaged in licensing transactions across the biopharma landscape.
Key therapeutic areas of focus for Amneal Pharmaceuticals include CNS Disorders (2 deals and trials), Cardiovascular (2 deals and trials), Autoimmune (1 deal and trial), and Infectious (1 deal and trial).
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Amneal Pharmaceuticals and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Amneal Pharmaceuticals's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.